Skip to main content
QMSQMS
QMS
  • Welcome to your QMS
  • Quality Manual
  • Procedures
  • Records
    • GP-001 Documents and records control
    • GP-002 Quality planning
    • GP-003 Audits
    • GP-004 Vigilance system
    • GP-005 HR and training
    • GP-007 Post-market surveillance
    • GP-009 Sales
      • R-009-001 Implementation plans
        • R-009-001 Iderma 20230301
        • R-009-001 Sermas 20230301
        • R-009-001 Galderma 20230727
        • R-009-001 Boehringer Ingelheim 20240207
        • R-009-001 Ribera Salud 20240708
        • R-009-001 Hospital del Mar 20240709
    • GP-010 Suppliers
    • GP-012 Design, Redesign and Development
    • GP-018 Infrastructure and facilities
    • GP-019 Software validation
    • GP-023 Change control management
    • GP-050 Data Protection
    • GP-051 Security violations
    • GP-052 Data Privacy Impact Assessment (DPIA)
  • TF_Legit.Health_Plus
  • Licenses and accreditations
  • External documentation
  • Procedures
  • Records
  • Records
  • GP-009 Sales
  • R-009-001 Implementation plans

R-009-001 Implementation plans

📄️ R-009-001 Iderma 20230301

- Governed by GP-009 Sales

📄️ R-009-001 Sermas 20230301

- Governed by GP-009 Sales

📄️ R-009-001 Galderma 20230727

- Governed by GP-009 Sales

📄️ R-009-001 Boehringer Ingelheim 20240207

- Governed by GP-009 Sales

📄️ R-009-001 Ribera Salud 20240708

- Governed by GP-009 Sales

📄️ R-009-001 Hospital del Mar 20240709

- Governed by GP-009 Sales

Previous
GP-009 Sales
Next
R-009-001 Iderma 20230301
All the information contained in this QMS is confidential. The recipient agrees not to transmit or reproduce the information, neither by himself nor by third parties, through whichever means, without obtaining the prior written permission of Legit.Health (AI LABS GROUP S.L.)